Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm BirthUnusual Whales·Aug 31 at 12:45 PMDARE+4.61%
Daré Bioscience CEO presents at Virtual Investor “Why Now” on-demand seriesPUBT·Aug 27 at 01:03 PMDARE+4.61%
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause SocietyUnusual Whales·Aug 26 at 12:47 PMDARE+4.61%
Daré Bioscience posts Phase 1 data showing topical sildenafil cream well tolerated in postmenopausal womenPUBT·Aug 26 at 12:45 PMDARE+4.61%
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect SegmentUnusual Whales·Aug 25 at 12:57 PMDARE+4.61%
Daré Bioscience DARE-HPV program advances with non-dilutive US government fundingPUBT·Aug 18 at 01:04 PMDARE+4.61%
DARÉ Bioscience CEO Sabrina Martucci Johnson Named to Forbes 2026 “50 Over 50: Innovation” List | DARE Stock NewsStockTitan·Aug 18 at 05:02 AMDARE+4.61%
Daré Bioscience prices USD 6 million registered direct offering at USD 1.37 per sharePUBT·Aug 17 at 12:36 PMDARE+4.61%
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE) and Daré Bioscience (DARE)businessinsider·Aug 16 at 12:46 AMBLTE+8.73%DARE+4.61%
